FDA Takes Action to Stop Marketing of Unapproved Time-Released Drug

The U.S. Food and Drug Administration (FDA) recently announced it will take action against companies that market unapproved, time-release drugs--often described as extended-release, long-acting, or sustained-release--that contain guaifenesin, a substance commonly used to relieve cough and cold symptoms to remove mucous from the lungs. The FDA estimates there are 20 such firms selling unapproved products.

"Today's action is another example of our commitment to ensure all drugs marketed in the United States that require FDA approval have that approval," said Steven K. Galson, M.D., M.P.H., director of the FDA's Center for Drug Evaluation and Research (CDER). "This benefits consumers because drugs that skirt the approval process may be unsafe, may not work, and often have inadequate labeling or are improperly manufactured."

This action does not affect products containing guaifenesin in immediate release form. FDA approval is necessary to ensure that the product releases its active ingredients safely and effectively, sustaining the intended effect over the entire time in which the product is intended to work.

Presently, only Adams Respiratory Therapeutics has obtained such FDA approval under the trade names of Mucinex and Humibid.

Companies marketing unapproved products containing guaifenesin in timed-release form are advised to stop manufacturing them within 90 days and cease shipping them in interstate commerce within 180 days. After these dates, companies wishing to market products containing guaifenesin in timed-release form must obtain approval or face regulatory action.

For more information, visit FDA's Unapproved Drugs Web site at www.fda.gov/cder/drug/unapproved_drugs/default.htm.

Download Center

HTML - No Current Item Deck
  • Safety Management Software - Free Demo

    IndustrySafe Safety Software’s comprehensive suite of modules help organizations to record and manage incidents, inspections, hazards, behavior based safety observations, and much more. Improve safety with an easy to use tool for tracking, notifying and reporting on key safety data.

  • Create Flexible Safety Dashboards

    IndustrySafe’s Dashboard Module allows organizations allows you to easily create and view safety KPIs to help you make informed business decisions. Our best of breed default indicators can also save you valuable time and effort in monitoring safety metrics.

  • Schedule and Record Observations

    IndustrySafe's Observations module allows managers, supervisors, and employees to conduct observations on employees involved in safety critical behavior. IndustrySafe’s pre-built BBS checklists may be used as is, or can be customized to better suit the needs of your organization.

  • Why Is Near Miss Reporting Important?

    A near miss is an accident that's waiting to happen. Learn how to investigate these close calls and prevent more serious incidents from occurring in the future.

  • Get the Ultimate Guide to Safety Training

    When it comes to safety training, no matter the industry, there are always questions regarding requirements and certifications. We’ve put together a guide on key safety training topics, requirements for certifications, and answers to common FAQs.

  • Industry Safe
comments powered by Disqus

OH&S Digital Edition

  • OHS Magazine Digital Edition - June 2019

    June 2019


      New Orleans Networking
      Heed These Summer Safety Tips
      Education, Skill Development, and Behavior Change
      What Good Looks Like
    View This Issue

Bulwark Quiz